A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

NCT04277624 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: fezolinetant - test formulation
DRUG: fezolinetant - reference formulation

Sponsor

Astellas Pharma Global Development, Inc.